Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2009 (2009), Article ID 183125, 3 pages
http://dx.doi.org/10.1155/2009/183125
Case Report

A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency

1Department of Medicine, University of Alberta Hospital, University of Alberta, Edmonton, AB, Canada T6G 2B7
2Department of Medical Genetics, University of Alberta/Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada T6G 2B7
3Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada T2M 0H5

Received 25 June 2009; Accepted 29 September 2009

Academic Editor: André Meégarbaneé

Copyright © 2009 Alexander A. C. Leung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Reimão, C. Morgado, I. T. Almeida et al., “3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: initial presentation in a young adult,” Journal of Inherited Metabolic Disease. In press. View at Publisher · View at Google Scholar · View at Scopus
  2. K. M. Gibson, S. B. Cassidy, L. H. Seaver et al., “Fatal cardiomyopathy associated with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency,” Journal of Inherited Metabolic Disease, vol. 17, no. 3, pp. 291–294, 1994. View at Google Scholar
  3. W. G. Hundley, D. Bluemke, J. G. Bogaert et al., “Society for cardiovascular magnetic resonance guidelines for reporting cardiovascular magnetic resonance examinations,” Journal of Cardiovascular Magnetic Resonance, vol. 11, no. 1, p. 5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. G. Howlett, R. S. McKelvie, J. M. O. Arnold et al., “Canadian cardiovascular society consensus conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials,” Canadian Journal of Cardiology, vol. 25, no. 2, pp. 85–105, 2009. View at Google Scholar · View at Scopus
  5. I. F. Kodde, J. van der Stok, R. T. Smolenski, and J. W. de Jong, “Metabolic and genetic regulation of cardiac energy substrate preference,” Comparative Biochemistry and Physiology A, vol. 146, no. 1, pp. 26–39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Kayser, “Disorders of ketone production and utilization,” Molecular Genetics and Metabolism, vol. 87, no. 4, pp. 281–283, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. L. Allard, K. N. Jeejeebhoy, and M. J. Sole, “The management of conditioned nutritional requirements in heart failure,” Heart Failure Reviews, vol. 11, no. 1, pp. 75–82, 2006. View at Publisher · View at Google Scholar · View at Scopus